News@UH

University of Hawaii System newsletter

Cancer Center Partnership with Guam Gets Grant

Posted on | November 6, 2009 | Comments Off

Mānoa’s Cancer Research Center of Hawaiʻi and the University of Guam received a $12.6 million combined grant award from the National Cancer Institute to support their cancer research partnership program. Of this amount, CRCH will receive more than $4.6 million, while the UOG will receive almost $8 million.

As the only partnership addressing cancer health disparities in Pacific Islanders, the CRCH/UOG partnership is characterized by a significant number of unique aspects and opportunities. Both Hawaiʻi and Guam have two distinct multi-ethnic populations that are very different from any other part of the U.S. In particular, more than one-third of the population of Guam is represented by Chamorros/part-Chamorros as well as a sizable community of other Micronesians.

The newly awarded partnership grant is intended to build on the achievements of the past six years, and to help sustain the unique partnership between UOG and CRCH with multi-purposed aims. These include: 1) increasing the cancer research activities and the number of faculty engaged in cancer research at UOG, 2) increasing the number of minority scientists of Pacific Islander ancestry engaged in cancer research, while providing pertinent undergraduate, graduate and post-graduate education and training opportunities for Pacific Islander students, 3) further strengthening the research focus at CRCH on cancer health disparities with emphasis on aspects of particular relevance for the people of Hawaiʻi and the Pacific, and 4) enhancing the awareness of cancer and cancer prevention and, ultimately, reducing the impact of cancer on the people of Guam, the other U.S.-associated Pacific Island territories and Hawaiʻi.

“This award will allow us to conduct regionally important research projects, and to address cancer health disparities in Guam and other parts of Micronesia,” says Professor Carl-Wilhelm Vogel, principal investigator.

Read the news release.

Comments